Significant differences exist with regard to time of discontinuation between different antipsychotic agents; for initial treatment, rapid onset/poor tolerability increases discontinuation, whilst for ...
Introduction Prescribing high-dose antipsychotics is typically reserved for individuals with treatment-resistant severe ...
This study investigated the 1-year incidence of extrapyramidal symptoms (EPS), as well as the incremental economic burden, in patients with schizophrenia initiating atypical antipsychotics. Objectives ...
KarXT (Karuna Therapeutics) met its primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia, the company has announced. KarXT is an oral coformulation of ...